Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/05/2858478/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/03/19/2848955/0/en/Taysha-Gene-Therapies-Reports-Full-Year-2023-Financial-Results-and-Provides-Corporate-and-Clinical-Updates.html
https://www.globenewswire.com//news-release/2024/03/14/2846713/0/en/Taysha-Gene-Therapies-to-Release-Full-Year-2023-Financial-Results-Provide-Corporate-and-Clinical-Updates-and-Host-Conference-Call-on-March-19.html
https://www.globenewswire.com//news-release/2024/03/01/2839099/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/02/29/2837908/0/en/Taysha-Gene-Therapies-Announces-Updates-to-TSHA-102-Clinical-Program-in-Rett-Syndrome.html
https://endpts.com/after-patient-outcry-taysha-starts-to-offload-drug-programs/
https://www.globenewswire.com//news-release/2024/02/15/2830347/0/en/Taysha-Gene-Therapies-Provides-Update-on-Deprioritized-Pipeline-Programs.html
https://www.globenewswire.com//news-release/2024/02/02/2822820/0/en/Taysha-Gene-Therapies-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com//news-release/2024/01/22/2812972/0/en/Taysha-Gene-Therapies-Announces-Poster-Presentation-on-TSHA-102-in-Rett-Syndrome-at-Upcoming-British-Paediatric-Neurology-Association-2024-Annual-Conference.html
https://www.globenewswire.com//news-release/2024/01/10/2807079/0/en/Taysha-Gene-Therapies-Announces-First-Pediatric-Patient-Dosed-with-TSHA-102-in-REVEAL-Phase-1-2-Pediatric-Trial-in-Rett-Syndrome.html